Accessibility Menu
Zhong Yuan Bio-Technology logo

Zhong Yuan Bio-Technology(OTC) ZHYBF

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-100%
5 YearN/A
1 Year-100%
1 Month-100%
$0.00
+0.00%
+0.00Today
Zhong Yuan Bio-Technology last closing stock price
MetricPriceDate
Last closeUSD 0.002025-11-21
Zhong Yuan Bio-Technology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-100%USD 2.022025-07-31
1 month-100%USD 2.022025-07-31
3 month-100%USD 2.022025-07-31
Year to date-100%USD 2.002024-12-27
1 year-100%USD 4.992024-10-15
3 year-100%USD 6.652022-11-22
Since inception-100%USD 0.512021-06-04

Zhong Yuan Bio-Technology Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.28M

Net Income (TTM)

$302.21K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-131654.89 (Low)

Price

$0.00

Volume

4,111

Open

$0.00

Previous Close

$2.02

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $2.02

Estimated Earnings Date

Mar 27, 2024

ZHYBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zhong Yuan Bio-Technology

Zhong Yuan Bio-Technology Holdings Limited specializes in the sale of plant-derived nervonic acid dietary supplements in China. The company operates through multiple segments, including dietary supplements, research and development services, royalties, and event organization.

Products and Services
  • Dietary supplements under the Muzhiyuan-Neuro Enhancer brand
  • Research and development services for neurological diseases
  • Technical support and early detection kits for brain diseases
Growth Outlook
  • Expansion in the dietary supplement market driven by increasing health awareness
  • Potential for growth in neurological disease treatments and early detection technologies
  • Strategic partnerships may enhance product offerings and market reach
Financial Highlights
  • Recent quarterly revenue of 348,878, showing resilience in a challenging market
  • Trailing twelve months (TTM) gross profit margin at 90.94%, indicating strong product demand
  • Operating income ratio of -32.07% reflects ongoing investment in R&D and marketing
Zhong Yuan Bio-Technology Holdings Limited is positioned in a growing sector, focusing on innovative health solutions. The company's commitment to research and development may lead to significant advancements in neurological health, appealing to a broad consumer base. Recent financial performance indicates a strong gross profit margin, suggesting effective cost management and product demand. The ongoing investments in R&D and marketing, while currently impacting operating income, may yield long-term benefits as the market for dietary supplements and neurological treatments expands.
AI Generated • Jul 16, 2026

Industry

Personal Products

Sector

Consumer Staples

Employees

23

CEO

Ting Ting Chang

Website

www.zhybiotech.com

Headquarters

Hong Kong, HK

ZHYBF Financials

Key Financial Metrics (TTM)

Gross Margin

90.94%

Operating Margin

11.70%

Net Income Margin

13.27%

Return on Equity

-109.67%

Return on Capital

11.05%

Return on Assets

9.54%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

17.71M

Volume

4.11K

Avg. Volume

0

Financials (TTM)

Gross Profit

$2.07M

Operating Income

$266.56K

EBITDA

$270.30K

Operating Cash Flow

$397.91K

Capital Expenditure

$0.00

Free Cash Flow

$397.91K

Cash & ST Invst.

$145.26K

Total Debt

$2.62M

Zhong Yuan Bio-Technology Performance Analysis

Zhong Yuan Bio-Technology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-03-31USD 2,328,526N/A
20232023-03-31USD 1,662,600-28.6%
20242024-03-31USD 2,278,24637.0%
Zhong Yuan Bio-Technology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-06-30N/A
Q22023-09-30-56.1%
Q32023-12-31-27.6%
Q42024-03-31N/A
Zhong Yuan Bio-Technology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-03-31USD -0.04N/A
20232023-03-31USD -0.09131.4%
20242024-03-31USD 0.02N/A
Zhong Yuan Bio-Technology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-06-30N/A
Q22023-09-30-86.9%
Q32023-12-31-244.8%
Q42024-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$348.88K

-28.8%

Gross Profit

$408.45K

+4.4%

Gross Margin

1.17%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

23

N/A

Net Income

-$73.64K

+89.2%

EBITDA

-$111.39K

+32.7%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Total Cash

$145.26K

-47.7%

Total Debt

$2.62M

+28.7%

Accounts Receivable

$1.47M

+315.7%

Inventory

$29.66K

-77.4%

Long Term Debt

$904.34K

+51.8%

Short Term Debt

$1.71M

+19.1%

Return on Assets

9.54%

N/A

Return on Invested Capital

38.88%

N/A

Free Cash Flow

$0.00

N/A

Operating Cash Flow

$0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SWSSFSwiss Water Decaffeinated Coffee Inc.
$4.20+0.00%
KPEAKun Peng International Ltd
$0.32+0.00%
BRCNFBurcon NutraScience Corporation
$1.28-8.57%
CELVCellev8 Nutrition Inc.
$0.07+16.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About ZHYBF

What is the current price of Zhong Yuan Bio-Technology?

Zhong Yuan Bio-Technology is trading at $0.00 per share.

What is the 52-week range for Zhong Yuan Bio-Technology?

Over the past 52 weeks, Zhong Yuan Bio-Technology has traded between $0.00 and $2.02.

How much debt does Zhong Yuan Bio-Technology have?

As of the most recent reporting period, Zhong Yuan Bio-Technology reported total debt of $2.62M.

How much cash does Zhong Yuan Bio-Technology have on hand?

Zhong Yuan Bio-Technology reported $145.26K in cash and cash equivalents in its most recent financial results.

What is Zhong Yuan Bio-Technology’s dividend yield?

Zhong Yuan Bio-Technology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services